EUVIMEDEUVIMED entdecken
Multizentrische Studie

Effect of Overweight and Obesity on the Response to Anti-TNF Therapy and Disease Course in Children With IBD

Sara Sila, Marina Aloi iD, Ugo Cucinotta, Laura Gianolio, Maya Granot, Ondrej Hradsky, Séamus Hussey, Ben Kang iD, Anna Karoliny, Kaija-Leena Kolho iD, Jan de Laffolie, Sara Lega und 13 weitere

Inflammatory Bowel Diseases · 2025

DOI: 10.1093/ibd/izae165 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Inflammatory Bowel Diseases, 2025. Verfasst von Sara Sila und 24 weiteren Autor:innen. Beteiligte Einrichtung: Children's Hospital Zagreb, University of Zagreb Medical School, Zagreb, Croatia. Hauptthemen laut MEDLINE: Tumor Necrosis Factor-alpha, Overweight, Inflammatory Bowel Diseases, Obesity. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study aimed to evaluate the effect of overweight and obesity at the start of anti-TNF therapy on treatment response and relapse rate in children with inflammatory bowel disease (IBD).

Methods

This multicenter, retrospective cohort study included 22 IBD centers in 14 countries. Children diagnosed with IBD in whom antitumor necrosis factor (anti-TNF) was introduced were included; those who were overweight/obese were compared with children who were well/undernourished.

Results

Six hundred thirty-seven children (370 [58%] males; mean age 11.5 ± 3.5 years) were included; 140 (22%) were in the overweight/obese group (OG) and 497 (78%) had BMI ≤1 SD (CG). The mean follow-up time was 141 ± 78 weeks (median 117 weeks). There was no difference in the loss of response (LOR) to anti-TNF between groups throughout the follow-up. However, children in OG had more dose escalations than controls. Male sex and lack of concomitant immunomodulators at the start of anti-TNF were risk factors associated with the LOR. There was no difference in the relapse rate in the first year after anti-TNF introduction; however, at the end of the follow-up, the relapse rate was significantly higher in the OG compared with CG (89 [64%] vs 218 [44%], respectively, P < .001). Univariate and multivariate analysis revealed that being overweight/obese, having UC, or being of male sex were factors associated with a higher risk for relapse.

Conclusions

Overweight/obese children with IBD were not at a higher risk of LOR to anti-TNF. Relapse in the first year after anti-TNF was introduced, but risk for relapse was increased at the end of follow-up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Necrosis Factor-alphaOverweightInflammatory Bowel DiseasesObesityHumansMaleFemaleChildRetrospective StudiesAdolescentRecurrenceFollow-Up StudiesInfliximabRisk FactorsTreatment Outcome

Stichwörter der Autor:innen

Crohn’s diseaseadalimumabinfliximabulcerative colitis

Substanzen

Tumor Necrosis Factor-alphaInfliximab

Autor:innen und Institutionen

  • Children's Hospital Zagreb, University of Zagreb Medical School, Zagreb, Croatia.
  • Pediatric Gastroenterology Unit, Sapienza University-Umberto I Hospital, Rome, Italy.
  • Pediatric Gastroenterology and Cystic Fibrosis Unit, Department of Human Pathology in Adulthood and Childhood, University of Messina, Italy.
  • Department of Gastroenterology, Hepatology and Nutrition, Royal Hospital for Children and Young People, Edinburgh, UK.
  • Pediatric Gastroenterology and Nutrition Unit, Sheba Medical Center, Tel-HaShomer, The Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Department of Paediatrics, Second Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.

ORCID-Profile: Marina Aloi, Ben Kang, Kaija-Leena Kolho, Lorenzo Norsa, Darja Urlep, Iva Hojsak

Zitieren

APA

Sila, S., Aloi, M., Cucinotta, U., Gianolio, L., Granot, M., Hradsky, O., Hussey, S., Kang, B., Karoliny, A., Kolho, K. L., de Laffolie, J., Lega, S., Matar, M., Norsa, L., Omiwole, S., Orlanski-Meyer, E., Palomino, L., Rohani, P., Scarallo, L., …, & Hojsak, I. (2025). Effect of Overweight and Obesity on the Response to Anti-TNF Therapy and Disease Course in Children With IBD. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izae165

Vancouver

Sila S, Aloi M, Cucinotta U, Gianolio L, Granot M, Hradsky O, et al. Effect of Overweight and Obesity on the Response to Anti-TNF Therapy and Disease Course in Children With IBD. Inflammatory Bowel Diseases. 2025. doi:10.1093/ibd/izae165

BibTeX
@article{Sila2025,
  author = {Sila, Sara and Aloi, Marina and Cucinotta, Ugo and Gianolio, Laura and Granot, Maya and Hradsky, Ondrej and Hussey, Séamus and Kang, Ben and Karoliny, Anna and Kolho, Kaija-Leena and de Laffolie, Jan and Lega, Sara and Matar, Manar and Norsa, Lorenzo and Omiwole, Sharon and Orlanski-Meyer, Esther and Palomino, Laura and Rohani, Pejman and Scarallo, Luca and Sladek, Margaret and Sohouli, Mohammad Hassan and Urlep, Darja and Yerushalmy-Feler, Anat and Zifman, Eyal and Hojsak, Iva},
  title = {Effect of Overweight and Obesity on the Response to Anti-TNF Therapy and Disease Course in Children With IBD},
  journal = {Inflammatory Bowel Diseases},
  year = {2025},
  doi = {10.1093/ibd/izae165}
}
Kostenlos starten →